Concepedia
Statistics
Publications
25
Citations
1.4K
H-Index
16
Active since
2011
Affiliations
University of Chicago(Current)
Dana-Farber Cancer Institute
Harvard University
Massachusetts General Hospital
The Ohio State University
Andrew Hantel is an author at University of Chicago specializing in medicine, public health, and oncology.
Top concepts
MedicineOncologyPublic HealthEpidemiologyHealth PolicyMedical EthicsClinical TrialsOutcomes ResearchCancer EpidemiologyClinical Epidemiology
Publications per year
2011–2024
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S. Welch, Allegra A. Petti, Christopher A. Miller et al. · New England Journal of Medicine · 2016 · 774 citations · Full text
Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome
Chadi Nabhan, Sonali M. Smith, Irene Helenowski et al. · British Journal of Haematology · 2011 · 94 citations
Lymphoid Neoplasia, Geriatric Oncology, Aging +14
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
Andrew Hantel, Brooke Peterson Gabster, Jason X. Cheng et al. · Journal for ImmunoTherapy of Cancer · 2018 · 66 citations · Full text
Validation of a financial toxicity (FT) grading system.
Jonas A. de Souza, Kristen Wroblewski, Ellie Proussaloglou et al. · Journal of Clinical Oncology · 2017 · 55 citations
Prognosis, Logistic Analysis, Financial Toxicity +22
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia
Niloufer Khan, Andrew Hantel, Randall W. Knoebel et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 39 citations
1–5 of 25